TET1 and cancer: In humans, mutated, inactive TET2 can lead to cancers, such as hematopoietic cancer (Salker et al., 2011; Kudo et al., 2012; Perez et al., 2012), yet TET1/2 knockout mice can survive with reduced 5hmC.